Sustainability in Biosimilar Therapeutic Peptides Industry 2025-2033
The increasing demand for targeted therapies further fuels this momentum, as healthcare providers and patients alike seek more precise and effective treatments for various conditions. Supportive regulatory environments across multiple countries are also playing a crucial role in facilitating the approval and market entry of these biosimilars.